Correction: A Genetic Screen for Dihydropyridine (DHP)-Resistant Worms Reveals New Residues Required for DHP-Blockage of Mammalian Calcium Channels.

Correction: A Genetic Screen for Dihydropyridine (DHP)-Resistant Worms Reveals New Residues Required for DHP-Blockage of Mammalian Calcium Channels.

Bibliographic Details
Main Authors:	Trevor C. Y. Kwok, Kwokyin Hui, Wojciech Kostelecki, Nicole Ricker, Guillermo Selman, Zhong-Ping Feng, Peter John Roy
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2009-02-01
Series:	PLoS Genetics
Online Access:	http://europepmc.org/articles/PMC2665012

Similar Items

A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels.
by: Trevor C Y Kwok, et al.
Published: (2008-05-01)

Correction: A Genetic Screen for Dihydropyridine (DHP)-Resistant Worms Reveals New Residues Required for DHP-Blockage of Mammalian Calcium Channels
Published: (2009-02-01)

Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
by: Shohei Shinomiya, et al.
Published: (2021-02-01)

Practical LAI Estimation with DHP Images in Complex Forest Structure with Rugged Terrain
by: Junghee Lee, et al.
Published: (2023-10-01)

The Role of Orientation of Surface Bound Dihydropyrrol-2-ones (DHP) on Biological Activity
by: Aditi Taunk, et al.
Published: (2019-07-01)

DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy.
by: Eunseo Jang, et al.
Published: (2019-01-01)

DHP-derivative and low oxygen tension effectively induces human adipose stromal cell reprogramming.
by: Min Ki Jee, et al.
Published: (2010-02-01)

PMX-DHP Therapy for Dyspnea and Deoxygenation in Severe COVID-19 Pneumonia: A Case Series
by: Kuwana T, et al.
Published: (2021-04-01)

A Standardized Clinical Data Harmonization Pipeline for Scalable AI Application Deployment (FHIR-DHP): Validation and Usability Study
by: Elena Williams, et al.
Published: (2023-03-01)

The efficacy of in vitro <i>Synergistes jonesii</i> inoculum in preventing DHP toxicity in steers fed leucaena-grass diets
by: Michael J. Halliday, et al.
Published: (2014-04-01)

Effectiveness of inoculation with rumen fluid containing <i>Synergistes jonesii</i> to control DHP toxicity in ruminants in eastern Indonesia
by: Michael J. Halliday, et al.
Published: (2019-07-01)

Anti-cancer effects of DHP107 on canine mammary gland cancer examined through in-vitro and in-vivo mouse xenograft models
by: Hyung-Kyu Chae, et al.
Published: (2024-01-01)

Ionic liquid[tbmim]Cl2/AlCl3 under ultrasonic irradiation towards synthesis of 1,4-DHP’s
by: B. Palakshi Reddy, et al.
Published: (2015-01-01)

Tissue pharmacokinetics of DHP107, a novel lipid‐based oral formulation of paclitaxel, in mice and patients by positron emission tomography
by: Byung Seok Moon, et al.
Published: (2021-09-01)

Prevalence of DHP toxicity and detection of <i>Synergistes jonesii</i> in ruminants consuming <i>Leucaena leucocephala</i> in eastern Indonesia
by: Michael J. Halliday, et al.
Published: (2014-04-01)

Leukocyte Profile of Mice Infected with Plasmodium berghei and Treated with Aqueous Extract of Strychnos Ligustrina and Its Combination with Dihydroartemisinin Piperaquine Phosphate (DHP)
by: Umi Cahyaningsih, et al.
Published: (2023-12-01)

The Characteristics of Patients with Severe COVID-19 Pneumonia Treated with Direct Hemoperfusion Using Polymyxin B-Immobilized Fiber Column (PMX-DHP)
by: Kuwana T, et al.
Published: (2022-08-01)

Adaptation and psychometric validation of Diabetes Health Profile (DHP-18) in patients with type 2 diabetes in Quito, Ecuador: a cross-sectional study
by: Ikram Benazizi, et al.
Published: (2021-07-01)

Elucidation of the Structure of Lignin–Carbohydrate Complexes in Ginkgo CW-DHP by <sup>13</sup>C-<sup>2</sup>H Dual Isotope Tracer
by: Kai Zhang, et al.
Published: (2021-09-01)

A Novel Epigenetic Silencing Pathway Involving the Highly Conserved 5'-3' Exoribonuclease Dhp1/Rat1/Xrn2 in Schizosaccharomyces pombe.
by: James Franklin Tucker, et al.
Published: (2016-02-01)

Green synthesis of C5–C6-unsubstituted 1,4-DHP scaffolds using an efficient Ni–chitosan nanocatalyst under ultrasonic conditions
by: Soumyadip Basu, et al.
Published: (2022-01-01)

JBP485, A Dual Inhibitor of Organic Anion Transporters (OATs) and Renal Dehydropeptidase-I (DHP-I), Protects Against Imipenem-Induced Nephrotoxicity
by: Chong Wang, et al.
Published: (2022-06-01)

DHP107, a novel oral paclitaxel formulation induces less peripheral neuropathic pain and pain-related molecular alteration than intravenous paclitaxel preparation in rat
by: Md. Mahbubur Rahman, et al.
Published: (2019-08-01)

Dihydropyridine calcium antagonists: conscious choice
by: Ostroumova O.D., et al.
Published: (2017-02-01)

Dihydropyridine calcium antagonists: conscious choice
by: O D Ostroumova, et al.
Published: (2017-03-01)

Pleiotropic features of dihydropyridine calcium channel antagonists
by: G S Anikin
Published: (2014-09-01)

ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS
by: Y. A. Karpov, et al.
Published: (2016-01-01)

Combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients with arterial hypertension and coronary heart disease: efficacy and safety
by: B. G. Iskanderov, et al.
Published: (2005-12-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS. POSITION OF NIFEDIPINE IN MODERN CARDIOLOGY PRACTICE
by: A. A. Garganeeva
Published: (2016-01-01)

The worm has turned: unexpected similarities between the transcription of enhancers and promoters in the worm and mammalian genomes.
by: Graham, B, et al.
Published: (2014)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES
by: E. V. Shilova, et al.
Published: (2016-01-01)

Central ECMO cannulation for severe dihydropyridine calcium channel blocker overdose
by: Cardenas Jose M., et al.
Published: (2023-12-01)

Ceramide synthases in mammalians, worms, and insects: emerging schemes
by: Voelzmann André, et al.
Published: (2010-12-01)

The Ca2+ influx through the mammalian skeletal muscle dihydropyridine receptor is irrelevant for muscle performance
by: Anamika Dayal, et al.
Published: (2017-09-01)

THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015-09-01)

THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015-09-01)

Dihydropyridine calcium blockers do not interfere with non-rapid eye movement sleep
by: GoEun Han, et al.
Published: (2022-10-01)

New aspects of using dihydropyridine calcium antagonists during coronary bypass surgery
by: Yuriy Yur'evich Vecherskiy, et al.
Published: (2010-12-01)

Mechanisms of Spindle Positioning: Lessons from Worms and Mammalian Cells
by: Sachin Kotak
Published: (2019-02-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
by: S. Y. Martsevich
Published: (2015-12-01)